ATE437630T1 - Vorrichtung und methode zur behandlung von urininkontinenz bei frauen - Google Patents

Vorrichtung und methode zur behandlung von urininkontinenz bei frauen

Info

Publication number
ATE437630T1
ATE437630T1 AT01918878T AT01918878T ATE437630T1 AT E437630 T1 ATE437630 T1 AT E437630T1 AT 01918878 T AT01918878 T AT 01918878T AT 01918878 T AT01918878 T AT 01918878T AT E437630 T1 ATE437630 T1 AT E437630T1
Authority
AT
Austria
Prior art keywords
ring
oxybutynin
women
urinary incontinence
treating urinary
Prior art date
Application number
AT01918878T
Other languages
English (en)
Inventor
Anu Mahashabde
Martha Kay
Donald Koelmel
Original Assignee
Duramed Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duramed Pharmaceuticals Inc filed Critical Duramed Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE437630T1 publication Critical patent/ATE437630T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Materials For Medical Uses (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
AT01918878T 2000-03-21 2001-03-21 Vorrichtung und methode zur behandlung von urininkontinenz bei frauen ATE437630T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/531,856 US6436428B1 (en) 2000-03-21 2000-03-21 Device and method for treating urinary incontinence in females
PCT/US2001/008978 WO2001070154A1 (en) 2000-03-21 2001-03-21 Device and method for treating urinary incontinence in females

Publications (1)

Publication Number Publication Date
ATE437630T1 true ATE437630T1 (de) 2009-08-15

Family

ID=24119337

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01918878T ATE437630T1 (de) 2000-03-21 2001-03-21 Vorrichtung und methode zur behandlung von urininkontinenz bei frauen

Country Status (12)

Country Link
US (2) US6436428B1 (de)
EP (2) EP2106785B1 (de)
JP (3) JP5265836B2 (de)
AT (1) ATE437630T1 (de)
AU (2) AU2001245901B2 (de)
BR (1) BR0109691A (de)
CA (1) CA2403475C (de)
DE (1) DE60139389D1 (de)
ES (1) ES2332262T3 (de)
IL (2) IL151858A0 (de)
MX (1) MXPA02009358A (de)
WO (1) WO2001070154A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436428B1 (en) * 2000-03-21 2002-08-20 Enhance Pharmaceuticals, Inc. Device and method for treating urinary incontinence in females
MX2013000002A (es) * 2001-07-27 2013-04-29 Teva Womens Health Inc Metodos de tratamiento de condiciones patologicas asociadas con vejiga hiperactiva.
CN1289064C (zh) * 2001-08-31 2006-12-13 先灵有限责任公司 药物输送体系
AU2002366800B2 (en) * 2001-12-20 2006-08-03 Femmepharma Holding Company, Inc. Vaginal delivery of drugs
DE10224556A1 (de) * 2002-05-31 2004-01-08 Grünenthal GmbH 1-Dimethylamino- 3-(3-methoxy-phenyl)2-methyl-pentan-3-ol entaltendes Arzneimittel in verschiedenen Formulierungen
FR2843303B1 (fr) * 2002-08-07 2006-01-21 R & D Pharma Nouvelles compositions pharmaceutiques destinees au traitement de l'incontinence urinaire
US6770025B2 (en) 2002-09-18 2004-08-03 Kimberly-Clark Worldwide, Inc. Molar shaped vaginal incontinence insert
US6676594B1 (en) 2002-09-18 2004-01-13 Kimberly-Clark Worldwide, Inc. C-shaped vaginal incontinence insert
US7263999B2 (en) * 2002-10-30 2007-09-04 Kabushiki Kaisha Kitazato Supply Ring for preventing prolapse of uterus and urinary bladder and ring for preventing prolapse of uterus and rectum
US6808485B2 (en) 2002-12-23 2004-10-26 Kimberly-Clark Worldwide, Inc. Compressible resilient incontinence insert
US7812010B2 (en) * 2003-01-02 2010-10-12 Femmepharma, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
US8007568B2 (en) * 2006-04-12 2011-08-30 Millipore Corporation Filter with memory, communication and pressure sensor
US10219884B2 (en) 2006-07-10 2019-03-05 First Quality Hygienic, Inc. Resilient device
US8177706B2 (en) 2006-07-10 2012-05-15 Mcneil-Ppc, Inc. Method of treating urinary incontinence
AU2007272601B2 (en) 2006-07-10 2014-01-16 First Quality Hygienic, Inc. Resilient device
US10004584B2 (en) 2006-07-10 2018-06-26 First Quality Hygienic, Inc. Resilient intravaginal device
US8613698B2 (en) 2006-07-10 2013-12-24 Mcneil-Ppc, Inc. Resilient device
EP2104489A2 (de) * 2006-12-26 2009-09-30 FemmePharma Holding Company, Inc. Topische verabreichung von danazol
ES2696999T3 (es) * 2007-06-26 2019-01-21 Allergan Pharmaceuticals Int Ltd Dispositivos de administración intravaginal de medicamentos para la administración de macromoléculas y medicamentos solubles en agua
US20110003000A1 (en) * 2009-07-06 2011-01-06 Femmepharma Holding Company, Inc. Transvaginal Delivery of Drugs
US20110028922A1 (en) * 2009-07-31 2011-02-03 Kay Dennis M Female External Incontinence Device
SG10201504864UA (en) * 2010-06-22 2015-07-30 Teva Womens Health Inc Intravaginal devices comprising anticholinergic agents, and methods of making thereof
US8980304B2 (en) * 2010-08-20 2015-03-17 Teva Women's Health, Inc. Barrel-shaped vaginal ring
JP2014506936A (ja) * 2011-03-03 2014-03-20 アラーガン インコーポレイテッド シリコーンベースの眼科製剤
ES2985998T3 (es) * 2015-01-30 2024-11-08 Ligalli B V Dispositivo de administración vaginal de fármacos
CN111801072A (zh) 2017-10-27 2020-10-20 锐诺维公司 用于训练盆底肌的装置、系统和方法
CN119952301A (zh) * 2025-04-10 2025-05-09 中国核动力研究设计院 一种远距离激光切割头及其调焦方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4286587A (en) 1978-10-11 1981-09-01 Alza Corporation Vaginal drug delivery system made from polymer
US4402695A (en) 1980-01-21 1983-09-06 Alza Corporation Device for delivering agent in vagina
ZA857643B (en) * 1984-10-12 1986-05-28 Akzo Nv Release system for two or more active substances
US4846844A (en) * 1987-08-31 1989-07-11 Eli Lilly And Company Antimicrobial coated implants
ES2137261T3 (es) 1992-05-13 1999-12-16 Alza Corp Administracion transdermica de oxibutinina.
US5900250A (en) 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
JP3066515B2 (ja) * 1992-11-11 2000-07-17 久光製薬株式会社 尿失禁治療用経皮投与製剤
JP3021661B2 (ja) 1994-03-07 2000-03-15 セラテック・インコーポレーテッド 薬剤含有接着複合体の経皮放出デバイス
US5635203A (en) 1994-09-29 1997-06-03 Alza Corporation Transdermal device having decreased delamination
US5677346A (en) 1995-01-31 1997-10-14 Sepracor, Inc. Treating urinary incontinence using (S)-desethyloxybutynin
US5532278A (en) 1995-01-31 1996-07-02 Sepracor, Inc. Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
US5601839A (en) 1995-04-26 1997-02-11 Theratech, Inc. Triacetin as a penetration enhancer for transdermal delivery of a basic drug
US5912268A (en) 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
US5674895A (en) * 1995-05-22 1997-10-07 Alza Corporation Dosage form comprising oxybutynin
US5785991A (en) 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
US5789442A (en) * 1996-01-18 1998-08-04 Schering Aktiengesellschaft Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents
US6171298B1 (en) 1996-05-03 2001-01-09 Situs Corporation Intravesical infuser
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
EP0927034A1 (de) 1996-09-19 1999-07-07 American Home Products Corporation Verfahren zur behandlung von harninkontinenz
DE19812413C1 (de) * 1998-03-20 1999-06-10 Sanol Arznei Schwarz Gmbh Transdermales Therapeutisches System (TTS) Oxybutynin enthaltend
US6087396A (en) 1998-10-05 2000-07-11 Situs Corporation Oxybutynin formulations and method of use
WO2000019997A1 (en) 1998-10-07 2000-04-13 Alza Corporation Controlled release dosage from comprising oxybutynin
US6056976A (en) * 1998-11-12 2000-05-02 Leiras Oy Elastomer, its preparation and use
US6436428B1 (en) * 2000-03-21 2002-08-20 Enhance Pharmaceuticals, Inc. Device and method for treating urinary incontinence in females
JP5017109B2 (ja) * 2004-07-09 2012-09-05 ザ・ポピュレイション・カウンシル，インコーポレイテッド プロゲステロン受容体モジュレーターを含有する徐放性組成物

Also Published As

Publication number Publication date
JP5265836B2 (ja) 2013-08-14
IL151858A (en) 2009-12-24
JP2003527404A (ja) 2003-09-16
CA2403475A1 (en) 2001-09-27
DE60139389D1 (de) 2009-09-10
US20020090390A1 (en) 2002-07-11
IL151858A0 (en) 2003-04-10
JP5986149B2 (ja) 2016-09-06
EP2106785A1 (de) 2009-10-07
AU2001245901B2 (en) 2004-10-07
WO2001070154A1 (en) 2001-09-27
CA2403475C (en) 2011-02-08
WO2001070154A9 (en) 2001-12-20
EP1278494B1 (de) 2009-07-29
EP2106785B1 (de) 2016-12-07
BR0109691A (pt) 2003-06-10
ES2332262T3 (es) 2010-02-01
US6436428B1 (en) 2002-08-20
JP2014210802A (ja) 2014-11-13
EP1278494A1 (de) 2003-01-29
EP1278494A4 (de) 2005-11-02
JP5675865B2 (ja) 2015-02-25
MXPA02009358A (es) 2003-09-25
HK1053254A1 (en) 2003-10-17
JP2013107895A (ja) 2013-06-06
AU4590101A (en) 2001-10-03

Similar Documents

Publication Publication Date Title
DE60139389D1 (de) Vorrichtung und methode zur behandlung von urininkontinenz bei frauen
NO20065380L (no) Anvendelse av R-(+)-2-(3-diisopropylamino-l-fenylpropyl)-4-hydroksymetyl-fenylisosmorsyrehydrogenfumarat for fremstilling av et medikament for behandling av urininkontinens og andre spasmogeniske sykdommer.
CY1108296T1 (el) Σετ χειρουργικων εργαλειων για τη θεραπεια της γυναικειας ακρατειας ουρων
BR0112361A (pt) Métodos para tratamento de condições oculares mediadas por inflamação
DE60220858D1 (de) Intravaginalvorrichtung zur Verhinderung von weiblicher Harninkontinenz
JP2003527404A5 (de)
DE60141145D1 (de)
ATE308937T1 (de) Ausdehnbare schlinge zur behandlung von harninkontinenz
FR2836820B1 (fr) Dispositif chirurgical et bandelette pour le traitement de l'incontinence urinaire d'effort chez la femme
AR031721A1 (es) Un dispositivo para la incontinencia urinaria y un metodo para hacer el mismo
MY149482A (en) Vaginal formulation of lidocaine for treating uterine dysrhythmia
MXPA05009816A (es) Composiciones y metodos para el tratamiento de la eyaculacion precoz.
DE69631674D1 (de) System oder gerät zur behandlung der ureter und/oder pyelo-ureter zusammenführung
NZ509894A (en) A "T" or "Y" shaped intravaginal device suitable for delivery of pharmaceuticals such as progesterone
WO2001013780A3 (en) Apparatus and method for anesthetizing the cervical region of a female
EP1506001A4 (de) Verfahren und zusammensetzungen zur behandlung von epithelläsionen in vagina, zervix und uterus
DK1150698T3 (da) Anvendelser af vaskulær endotelvækstfaktor i behandlingen af erektil dysfunktion
ATE326199T1 (de) Vorrichtung zur gleichzeitigen austragung von wirkstoffen in den cervikal- und vaginalkanal
GR3035358T3 (en) Use of cyclooxygenase inhibitors for the manufacture of a medicament for enhancing uterine blood perfusion
DE60206888D1 (de) Harninkontinenzvorrichtung
UA31546A (uk) Спосіб деривації сечі після цистектомії
DE60027168D1 (de) Adrenomedullin zur behandlung von störungen des harnlassens
Toeplitz et al. RHINOSCLEROMA.
KR980008196A (ko) 여성 질 건강 운동기구
UA95691C2 (ru) Фармацевтическая вагинальная композиция и ее применение

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties